Syntal Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Syntal Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-77,963	Closed	-$21.2M	–	145
2019 Q3	$21.2M	Hold	77,963	–	–	5.49%	4
2019 Q2	$21.5M	Buy	+77,963	New	+$19.2M	4.62%	4
2017 Q3	–	Sell	-3,894	Closed	-$628K	–	114
2017 Q2	$628K	Sell	3,894 -10	-0.3%	-$1.62K	0.14%	29
2017 Q1	$603K	Buy	3,904 +1,382	+55%	+$191K	0.5%	23
2016 Q4	$295K	Buy	+2,522	New	+$288K	0.27%	74

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Syntal Capital Partners's IDXX Position: Q4 2019 in Review

Syntal Capital Partners sold out of Idexx Laboratories (IDXX) in Q4 2019, closing a stake of 77,963 shares — an estimated $21.2M sold.

Syntal Capital Partners first reported a position in IDXX in Q4 2016 and held it in 5 quarters. The position peaked at $21.5M in Q2 2019. 761 funds tracked by Wall St. Rank hold IDXX as of Q4 2019.

Syntal Capital Partners reported no remaining Idexx Laboratories position as of Q4 2019 after selling out during the quarter.
Syntal Capital Partners sold 77,963 Idexx Laboratories shares in Q4 2019, an estimated $21.2M.
Syntal Capital Partners first reported a position in Idexx Laboratories in Q4 2016 and held it in 5 quarters.
Syntal Capital Partners's Idexx Laboratories position peaked at $21.5M in Q2 2019.
761 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2019.

Based on Syntal Capital Partners's 13F filing for Q4 2019, filed 10 Feb 2020.